Regulatory and T effector cells have overlapping low to high ranges in TCR affinities for self during demyelinating disease

Journal of Immunology

Volumn 195, Issue 9, 2015, Pages 4162-4170

  Hood, Jennifer D ^a   Zarnitsyna, Veronika I ^b   Zhu, Cheng ^c   Evavold, Brian D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN OLIGODENDROCYTE GLYCOPROTEIN; T LYMPHOCYTE RECEPTOR; TETRAMER; AUTOANTIGEN; LYMPHOCYTE ANTIGEN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CD4+ T LYMPHOCYTE; CELL ASSAY; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DEMYELINATING DISEASE; DISEASE ACTIVITY; EFFECTOR CELL; FEMALE; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MALE; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; REGULATORY T LYMPHOCYTE; ANIMAL; BRAIN; C57BL MOUSE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; LYMPH NODE; METABOLISM;

ANIMALS; AUTOANTIGENS; BRAIN; CD4-POSITIVE T-LYMPHOCYTES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES, REGULATORY;

EID: 84945124349     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501464     Document Type: Article

References (58)

1. Danke, N. A., D. M. Koelle, C. Yee, S. Beheray, and W. W. Kwok. 2004. Autoreactive T cells in healthy individuals. J. Immunol. 172: 5967-5972.
2. Sakaguchi, S., N. Sakaguchi, M. Asano, M. Itoh, and M. Toda. 1995. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155: 1151-1164.
3. Brunkow, M. E., E. W. Jeffery, K. A. Hjerrild, B. Paeper, L. B. Clark, S. A. Yasayko, J. E. Wilkinson, D. Galas, S. F. Ziegler, and F. Ramsdell. 2001. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27: 68-73.
4. Bennett, C. L., J. Christie, F. Ramsdell, M. E. Brunkow, P. J. Ferguson, L. Whitesell, T. E. Kelly, F. T. Saulsbury, P. F. Chance, and H. D. Ochs. 2001. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27: 20-21.
5. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol. 2: 301-306.
6. + regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol. 168: 4399-4405.
7. Bautista, J. L., C. W. Lio, S. K. Lathrop, K. Forbush, Y. Liang, J. Luo, A. Y. Rudensky, and C. S. Hsieh. 2009. Intraclonal competition limits the fate determination of regulatory T cells in the thymus. Nat. Immunol. 10: 610-617.
8. + cells is limited to small clonal sizes. J. Exp. Med. 206: 2121-2130.
9. Burchill, M. A., J. Yang, K. B. Vang, J. J. Moon, H. H. Chu, C. W. Lio, A. L. Vegoe, C. S. Hsieh, M. K. Jenkins, and M. A. Farrar. 2008. Linked T cell receptor and cytokine signaling govern the development of the regulatory T cell repertoire. Immunity 28: 112-121.
10. Lio, C. W., and C. S. Hsieh. 2008. A two-step process for thymic regulatory T cell development. Immunity 28: 100-111.
11. + regulatory T cells. Immunity 27: 493-504.
12. + T cells. Nat. Immunol. 10: 1155-1161.
13. + T cells with identical antigen receptors. Nat. Commun. 5: 5061.
14. + T cell responses. J. Exp. Med. 208: 81-90.
15. Rosenthal, K. M., L. J. Edwards, J. J. Sabatino, Jr., J. D. Hood, H. A. Wasserman, C. Zhu, and B. D. Evavold. 2012. Low 2-dimensional CD4 T cell receptor affinity for myelin sets in motion delayed response kinetics. PLoS One 7: e32562.
16. + T cell response to a rheumatoid arthritis-associated antigen. Arthritis Rheum. 52: 1885-1896.
17. + T cells directed to self-antigens. Eur. J. Immunol. 33: 1409-1417.
18. Korn, T., J. Reddy, W. Gao, E. Bettelli, A. Awasthi, T. R. Petersen, B. T. Bäckström, R. A. Sobel, K. W. Wucherpfennig, T. B. Strom, et al. 2007. Myelin-specific regulatory T cells accumulate in the CNS but fail to control autoimmune inflammation. Nat. Med. 13: 423-431.
19. regs involves IL-6-mediated signaling. Sci. Transl. Med. 5: 170ra15.
20. Feng, Y., A. Arvey, T. Chinen, J. van der Veeken, G. Gasteiger, and A. Y. Rudensky. 2014. Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus. Cell 158: 749-763.
21. Zheng, Y., S. Josefowicz, A. Chaudhry, X. P. Peng, K. Forbush, and A. Y. Rudensky. 2010. Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463: 808-812.
22. Bailey-Bucktrout, S. L., M. Martinez-Llordella, X. Zhou, B. Anthony, W. Rosenthal, H. Luche, H. J. Fehling, and J. A. Bluestone. 2013. Self-antigen-driven activation induces instability of regulatory T cells during an inflammatory autoimmune response. Immunity 39: 949-962.
23. Haribhai, D., W. Lin, L. M. Relland, N. Truong, C. B. Williams, and T. A. Chatila. 2007. Regulatory T cells dynamically control the primary immune response to foreign antigen. J. Immunol. 178: 2961-2972.
24. Ford, M. L., and B. D. Evavold. 2003. Regulation of polyclonal T cell responses by an MHC anchor-substituted variant of myelin oligodendrocyte glycoprotein 35-55. J. Immunol. 171: 1247-1254.
25. Gilbert, P.-A., A. Garnier, D. Jacob, and A. Kamen. 2000. On-line measurement of green fluorescent protein (GFP) fluorescence for the monitoring of recombinant adenovirus production. Biotechnol. Lett. 22: 561-567.
26. Dumaswala, U. J., M. J. Wilson, T. José, and D. L. Daleke. 1996. Glutamine- and phosphate-containing hypotonic storage media better maintain erythrocyte membrane physical properties. Blood 88: 697-704.
27. Kersh, A. E., L. J. Edwards, and B. D. Evavold. 2014. Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread. J. Immunol. 193: 4429-4438.
28. + T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen. J. Immunol. 180: 4451-4457.
29. Huang, J., V. I. Zarnitsyna, B. Liu, L. J. Edwards, N. Jiang, B. D. Evavold, and C. Zhu. 2010. The kinetics of two-dimensional TCR and pMHC interactions determine T-cell responsiveness. Nature 464: 932-936.
30. Chesla, S. E., P. Selvaraj, and C. Zhu. 1998. Measuring two-dimensional receptor-ligand binding kinetics by micropipette. Biophys. J. 75: 1553-1572.
31. Huang, J., L. J. Edwards, B. D. Evavold, and C. Zhu. 2007. Kinetics of MHC-CD8 interaction at the T cell membrane. J. Immunol. 179: 7653-7662.
32. Jiang, N., J. Huang, L. J. Edwards, B. Liu, Y. Zhang, C. D. Beal, B. D. Evavold, and C. Zhu. 2011. Two-stage cooperative T cell receptor-peptide major histocompatibility complex-CD8 trimolecular interactions amplify antigen discrimination. Immunity 34: 13-23.
33. Schubert, D. A., S. Gordo, J. J. Sabatino, Jr., S. Vardhana, E. Gagnon, D. K. Sethi, N. P. Seth, K. Choudhuri, H. Reijonen, G. T. Nepom, et al. 2012. Self-reactive human CD4 T cell clones form unusual immunological synapses. J. Exp. Med. 209: 335-352.
34. Ohkura, N., M. Hamaguchi, H. Morikawa, K. Sugimura, A. Tanaka, Y. Ito, M. Osaki, Y. Tanaka, R. Yamashita, N. Nakano, et al. 2012. T cell receptor stimulation-induced epigenetic changes and Foxp3 expression are independent and complementary events required for Treg cell development. Immunity 37: 785-799.
35. Scharer, C. D., B. G. Barwick, B. A. Youngblood, R. Ahmed, and J. M. Boss. 2013. Global DNA methylation remodeling accompanies CD8 T cell effector function. J. Immunol. 191: 3419-3429.
36. Tang, Q., K. J. Henriksen, M. Bi, E. B. Finger, G. Szot, J. Ye, E. L. Masteller, H. McDevitt, M. Bonyhadi, and J. A. Bluestone. 2004. In vitro-expanded antigen-specific regulatory T cells suppress autoimmune diabetes. J. Exp. Med. 199: 1455-1465.
37. + T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J. Exp. Med. 199: 1467-1477.
38. Weaver, C. T., A. Saparov, L. A. Kraus, W. O. Rogers, R. D. Hockett, and R. P. Bucy. 1998. Heterogeneity in the clonal T cell response. Implications for models of T cell activation and cytokine phenotype development. Immunol. Res. 17: 279-302.
39. H17 and regulatory T cells. Nature 441: 235-238.
40. + T cells. J. Immunol. 176: 3028-3036.
41. + T cell repertoire in the transition from effector to memory. Immunity 28: 533-545.
42. + T regulatory cells. J. Immunol. 184: 3433-3441.
43. Akimova, T., U. H. Beier, L. Wang, M. H. Levine, and W. W. Hancock. 2011. Helios expression is a marker of T cell activation and proliferation. PLoS One 6: e24226.
44. + regulatory T cells. J. Immunol. 188: 976-980.
45. Cheng, C., S. Wang, P. Ye, X. Huang, Z. Liu, J. Wu, Y. Sun, A. Xie, G. Wang, and J. Xia. 2014. "Default" generated neonatal regulatory T cells are hypomethylated at conserved non-coding sequence 2 and promote long-term cardiac allograft survival. Immunology 143: 618-630.
46. Vahl, J. C., C. Drees, K. Heger, S. Heink, J. C. Fischer, J. Nedjic, N. Ohkura, H. Morikawa, H. Poeck, S. Schallenberg, et al. 2014. Continuous T cell receptor signals maintain a functional regulatory T cell pool. Immunity 41: 722-736.
47. + regulatory T cells in tumors from mice and humans". J. Immunol. 194: 3533-3534.
48. + regulatory T cells in tumors from mice and humans. J. Immunol. 194: 878-882.
49. + regulatory T cells is controlled by ultraviolet B exposure in the skin. J. Immunol. 193: 5488-5497.
50. Huppa, J. B., M. Axmann, M. A. Mörtelmaier, B. F. Lillemeier, E. W. Newell, M. Brameshuber, L. O. Klein, G. J. Schütz, and M. M. Davis. 2010. TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity. Nature 463: 963-967.
51. Hatterer, E., M. Touret, M. F. Belin, J. Honnorat, and S. Nataf. 2008. Cerebro-spinal fluid dendritic cells infiltrate the brain parenchyma and target the cervical lymph nodes under neuroinflammatory conditions. PLoS One 3: e3321.
52. + Treg cells in the inflamed CNS are insensitive to IL-6-driven IL-17 production. Eur. J. Immunol. 42: 1174-1179.
53. Toker, A., D. Engelbert, G. Garg, J. K. Polansky, S. Floess, T. Miyao, U. Baron, S. Düber, R. Geffers, P. Giehr, et al. 2013. Active demethylation of the Foxp3 locus leads to the generation of stable regulatory T cells within the thymus. J. Immunol. 190: 3180-3188.
54. + regulatory T cells upon peripheral proinflammatory immunization. J. Immunol. 185: 3829-3833.
55. Apostolou, I., A. Sarukhan, L. Klein, and H. von Boehmer. 2002. Origin of regulatory T cells with known specificity for antigen. Nat. Immunol. 3: 756-763.
56. Relland, L. M., M. K. Mishra, D. Haribhai, B. Edwards, J. Ziegelbauer, and C. B. Williams. 2009. Affinity-based selection of regulatory T cells occurs independent of agonist-mediated induction of Foxp3 expression. J. Immunol. 182: 1341-1350.
57. + regulatory T cells in vivo. J. Exp. Med. 198: 249-258.
58. Moran, A. E., K. L. Holzapfel, Y. Xing, N. R. Cunningham, J. S. Maltzman, J. Punt, and K. A. Hogquist. 2011. T cell receptor signal strength in Treg and iNKT cell development demonstrated by a novel fluorescent reporter mouse. J. Exp. Med. 208: 1279-1289.